The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits.
(1998) British Journal of Pharmacology — Vol. 125, n° 5, p. 1005-1012 (1998)
Files
9846638.pdf
Open Access - Adobe PDF
- 361.48 KB
Details
- Authors
- Abstract
- 1. CHO cells expressing the alpha(1C-a) subunit (cardiac isoform) and the alpha(1C-b) subunit (vascular isoform) of the voltage-dependent L-type Ca2+ channel were used to investigate whether tissue selectivity of Ca2+ channel blockers could be related to different affinities for alpha1C isoforms. 2. Inward current evoked by the transfected alpha1 subunit was recorded by the patch-clamp technique in the whole-cell configuration. 3. Neutral dihydropyridines (nifedipine, nisoldipine, (+)-PN200-110) were more potent inhibitors of alpha(1C-)b-subunit than of alpha(1C-a)-subunit. This difference was more marked at a holding potential of -100 mV than at -50 mV. SDZ 207-180 (an ionized dihydropyridine) exhibited the same potency on the two isoforms. 4. Pinaverium (ionized non-dihydropyridine derivative) was 2 and 4 fold more potent on alpha(1C-a) than on alpha(1C-b) subunit at Vh of -100 mV and -50 mV, respectively. Effects of verapamil were identical on the two isoforms at both voltages. 5. [3H]-(+)-PN 200-110 binding experiments showed that neutral dihydropyridines had a higher affinity for the alpha(1C-b) than for the alpha(1C-a) subunit. SDZ 207-180 had the same affinity for the two isoforms and pinaverium had a higher affinity for the alpha(1C-a) subunit than for the alpha(1C-b) subunit. 6. These results indicate marked differences among Ca2+ channel blockers in their selectivity for the alpha(1C-a) and alpha(1C-b) subunits of the Ca2+ channel.
- Affiliations
Citations
Morel, N., Buryi, V., Feron, O., Gomez, J. P., Christen, M. O., & Godfraind, T. (1998). The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits. British Journal of Pharmacology, 125(5), 1005-1012. https://doi.org/10.1038/sj.bjp.0702162 (Original work published 1998)